Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy
- PMID: 28178049
- PMCID: PMC5322246
- DOI: 10.1097/AOG.0000000000001895
Single Health System Adherence to 2012 Cervical Cancer Screening Guidelines at Extremes of Age and Posthysterectomy
Abstract
Objective: To estimate the proportion of guideline nonadherent Pap tests in women aged younger than 21 years and older than 65 years and posthysterectomy in a single large health system. Secondary objectives were to describe temporal trends and patient and health care provider characteristics associated with screening in these groups.
Methods: A retrospective cross-sectional chart review was performed at Fairview Health Services and University of Minnesota Physicians. Reasons for testing and patient and health care provider information were collected. Tests were designated as indicated or nonindicated per the 2012 cervical cancer screening guidelines. Point estimates and descriptive statistics were calculated. Patient and health care provider characteristics were compared between indicated and nonindicated groups using χ and Wilcoxon rank-sum tests.
Results: A total of 3,920 Pap tests were performed between September 9, 2012, and August 31, 2014. A total of 257 (51%; 95% confidence interval [CI] 46.1-54.9%) of tests in the younger than 21 years group, 536 (40%; 95% CI 37.7-43.1%) in the older than 65 years group, and 605 (29%; 95% CI 27.1-31.0%) in the posthysterectomy group were not indicated. White race in the older than 65 years group was the only patient characteristic associated with receipt of a nonindicated Pap test (P=.007). Health care provider characteristics associated with nonindicated Pap tests varied by screening group. Temporal trends showed a decrease in the proportion of nonindicated tests in the younger than 21 years group but an increase in the posthysterectomy group.
Conclusion: For women aged younger than 21 years and older than 65 years and posthysterectomy, 35% of Pap tests performed in our health system were not guideline-adherent. There were no patient or health care provider characteristics associated with guideline nonadherent screening across all groups.
Figures
Similar articles
-
Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.J Low Genit Tract Dis. 2019 Oct;23(4):253-258. doi: 10.1097/LGT.0000000000000484. J Low Genit Tract Dis. 2019. PMID: 31592972 Free PMC article.
-
Cervical Cancer Screening Guideline Adherence Before and After Guideline Changes in Pennsylvania Medicaid.Obstet Gynecol. 2017 Jan;129(1):66-75. doi: 10.1097/AOG.0000000000001804. Obstet Gynecol. 2017. PMID: 27926644
-
Differences in cervical cancer screening and follow-up for black and white women in the United States.Gynecol Oncol. 2021 Feb;160(2):369-374. doi: 10.1016/j.ygyno.2020.11.027. Epub 2020 Dec 13. Gynecol Oncol. 2021. PMID: 33323276
-
Excess Cost of Cervical Cancer Screening Beyond Recommended Screening Ages or After Hysterectomy in a Single Institution.J Low Genit Tract Dis. 2018 Jul;22(3):184-188. doi: 10.1097/LGT.0000000000000400. J Low Genit Tract Dis. 2018. PMID: 29733302 Free PMC article.
-
Cervical Cancer Screening for Patients on the Female-to-Male Spectrum: a Narrative Review and Guide for Clinicians.J Gen Intern Med. 2015 Dec;30(12):1857-64. doi: 10.1007/s11606-015-3462-8. Epub 2015 Jul 10. J Gen Intern Med. 2015. PMID: 26160483 Free PMC article. Review.
Cited by
-
Cervical Cancer Screening in Patients with Total Hysterectomy in a Diagnostic Center at Mexico City.Int J Prev Med. 2022 Feb 23;13:29. doi: 10.4103/ijpvm.IJPVM_101_20. eCollection 2022. Int J Prev Med. 2022. PMID: 35392319 Free PMC article.
-
Unindicated cervical cancer screening in adolescent females within a large healthcare system in the United States.Am J Obstet Gynecol. 2021 Dec;225(6):649.e1-649.e9. doi: 10.1016/j.ajog.2021.07.005. Epub 2021 Jul 10. Am J Obstet Gynecol. 2021. PMID: 34256029 Free PMC article.
-
Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.JAMA Netw Open. 2021 Apr 1;4(4):e218373. doi: 10.1001/jamanetworkopen.2021.8373. JAMA Netw Open. 2021. PMID: 33914050 Free PMC article.
-
Assessing Physician Adherence to Guidelines for Cervical Cancer Screening and Management of Abnormal Screening Results.J Low Genit Tract Dis. 2020 Oct;24(4):337-342. doi: 10.1097/LGT.0000000000000558. J Low Genit Tract Dis. 2020. PMID: 32976292 Free PMC article.
-
Effect of an Electronic Health Record Decision Support Alert to Decrease Excess Cervical Cancer Screening.J Low Genit Tract Dis. 2019 Oct;23(4):253-258. doi: 10.1097/LGT.0000000000000484. J Low Genit Tract Dis. 2019. PMID: 31592972 Free PMC article.
References
-
- Moyer VA. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Annals of internal medicine. 2012 Jun 19;156(12):880–91. W312. - PubMed
-
- Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American journal of clinical pathology. 2012 Apr;137(4):516–42. - PubMed
-
- ACOG Practice Bulletin Number 131: Screening for cervical cancer. Obstetrics and gynecology. 2012 Nov;120(5):1222–38. - PubMed
-
- Practice Bulletin No. 168: Cervical Cancer Screening and Prevention. Obstetrics and gynecology. 2016 Oct;128(4):e111–30. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
